References
- Lehmann KG, Gonzales E, Tri BD, Vaziri ND. Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilation. Am Heart J 1999; 137: 274–83.
- Smyth DW, Martin JF, Michalis L, Bucknall CA, Jewitt DE. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest 1993; 23: 361–7.
- Gustavsson CG, Persson S, Thorvinger BO, Hedner P. Association between pre-PTCA blood haemoglobin con-centration and the risk of symptomatic restenosis after suc-cessful PTCA of primary coronary stenoses. J Cardiovasc Risk 1997; 4: 37–40.
- Heras M, Chesebro JH, Penny WJ, Bailey KR, Lam J, Holmes DR, Reeder GS, Badimon L, Fuster V. Influence of adequate heparin dosage in arterial angioplasty in a porcine model. Circulation 1988; 78: 654–60.
- Bienvenu JG, Tanguay JF, Chauvet P, Merhi Y. Relation-ship between platelets and neutrophil adhesion and neoin-timal growth after repeated arterial wall injury induced by angioplasty in pigs. J Vasc Res 2001; 38: 153–62.
- Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 1995; 92: 31–8.
- Symonides B, Januszewicz A, Rowinski 0, Januscewicz M, Chodakowska J, Berent H, Kuczynska K, Szmigielski C, Malek G, Januszewicz W Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angio-plasty in patients with atherosclerotic renal artery steno sis. J Cardiovasc Risk 1999; 6: 269–72.
- Bach R, Jung F, Kohsiek I, Ozbek C, Spitzer S, Scheller B, Dyckmans J, Schieffer H. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty. Thromb Res 1994; 74 (suppl 1): S55–67.
- Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyper-plasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991; 17 (suppl B): 77B–88B.
- Weintraub WS, Kosinki AS, Brow III CL, King III SB. Can restenosis after percutaneous coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993; 21: 6–14.
- Haudenschild CC. Pathobiology of restenosis after angio-plasty. Am J Med 1993; 94 (suppl 4A): 40S–44S.
- Forrester JH, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the develop-ment of new preventive theraphies. J Am Coll Cardiol 1991; 17: 758–69.
- Pizzuli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998; 19: 80–4.
- Tofler GH, Brezinski D, Schafer AT, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE. Concurrent morning increase in platelet aggre-gability and the risk of MI and sudden cardiac death. N Engl .1 Med 1987; 316: 1514–8.
- Fitzgerald DJ, Roy L, Castella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983–9.
- Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in appearently healthy men. Circulation 1991; 84: 613–7.
- Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of MI. N Engl J Med 1990; 322: 1549–54.
- Elwood PC, Renaud S, Sharp DS, Beswick AD, O’Brien JR, Yarnell WG. Ischemic heart disease and platelet aggrega-tion. The Caerphilly Collaborative Heart Disease Study. Circulation 1991; 83: 38–44.
- Martin JF, Trowbridge EA, Salmon G, Plumb J. The bio-logical significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakary-ocyte nuclear DNA concentration. Thromb Res 1983; 32: 443–60.
- Haver VM, Gear ARL. Functional fractionation of platelets. J Lab Clin Med 1981; 97: 187–204.
- Ross R. The pathogenesis of atherosclerosis - An update. N Engl .1 Med 1986; 314: 488–500.
- Steele PM, Chesebro JH, Stanson AW, Holmes DR, Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty: natural history of pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105–12.
- Wilentz JR, Sanborn TA, Haudenschild CC, Valeri RC, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation 1987; 75: 636–42.
- Lam JYT, Chesebro JH, Steele PM, Dewanjee MK, Badimon L, Fuster V. Deep arterial injury during experi-mental angioplasty: Relationship to a positive “indium-labelled platelet scintigram, quantitative platelet deposi-tion and mural thrombosis. J Am Coll Cardiol 1986; 8: 1380–6.
- Libby P, Warner SJC, Salomon RN, Birinyi LK. Production of platelet-derived growth factor-like mitogen by smooth muscle cells from human atheroma. N Engl J Med 1988; 318: 1493–8.
- Assoian RK, Grotendorst GR, Miller DM, Sporn MB. Cellular transformation by coordinate action of three pep-tid growth factors from human platelets. Nature 1984; 309: 804–6.
- Nobuyoshi M, Kimura T, Ohoshi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 1991; 17: 433–9.
- Martin JF, Trowbridge EA, Salmon GL, Slater DN. The relationship between platelets and megakaryocyte volumes. Thromb Res 1982; 28: 447–59.
- Kristensen SD, Roberts KM, Kishk YT, Martin JF. Accelerated atherogenesis occurs following platelet destruc-tion and increases in megakaryocyte size and DNA content. Eur J Clin Invest 1990; 20: 239–47.
- Gladwyn A-M, Martin JF. The control of megakaryocyte ploidy and platelet production: biology and pathology. Int J Cell Cloning 1990; 8: 291–8.